![]() Yuanyi (Shandong) Gene Technology Yuanyi (Shandong) Gene Technology Co., Ltd. (源宜 基因科技股份有限公司) is specialized in providing cutting-edge research technologies in life sciences. | ![]() Impel Pharmaceuticals Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. | ![]() Tonix Pharmaceuticals Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders. | ![]() Precision Medicine Group Precision Medicine Group (PMG) is a company that specializes in advising clients on clinical trials, drug discovery, and commercialization. | ![]() Brinton Pharmaceuticals Brinton Pharmaceuticals is a pharmaceutical company operating in therapeutic and manufacturing areas. | |
Founding Date | Founding Date 2009 | Founding Date 2008 | Founding Date 2007 | Founding Date 2012 | Founding Date 2014 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations HQ | Locations Seattle, US HQ | Locations Chatham, US HQ Montréal, CA Dublin, IE Dartmouth, US New York, US San Diego, US | Locations Bethesda, US HQ | Locations Pune, IN HQ Kumasi, GH London, GB Redding, US Sheridan, US |
Employees | Employees N/A | Employees 6710% increase | Employees 1633% increase | Employees 4044% increase | Employees 660 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 5.8 m | Valuation ($) 23.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $12.7m (FY, 2022) | Revenue (est.) $13.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $6.5m (FY, 2022) | Cost of goods $6.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $6.2m (FY, 2022) | Gross profit $6.5m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($106.3m) (FY, 2022) | Net income ($124m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 108.1m | Total funding raised $ 15.5m | Total funding raised $ 359.7m | Total funding raised $ 12m |

Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.
View company
Tonix Pharmaceuticals develops pharmaceutical products for central nervous system disorders.
View company
Precision Medicine Group (PMG) is a company that specializes in advising clients on clinical trials, drug discovery, and commercialization.
View company
Brinton Pharmaceuticals is a pharmaceutical company operating in therapeutic and manufacturing areas.
View company